-

KKR & Co. Inc. Announces Conversion Rate for Mandatory Convertible Preferred Stock

NEW YORK--(BUSINESS WIRE)--KKR & Co. Inc. (NYSE: KKR) announced today that its outstanding 6.00% Series C Mandatory Convertible Preferred Stock (the “Preferred Stock”), will automatically convert into shares of the Company’s common stock on September 15, 2023 (the “conversion date”). The conversion rate for each share of Preferred Stock will be 1.1700 shares of the Company’s common stock. Cash will be paid in lieu of fractional shares of common stock.

As previously announced, holders of record at the close of business on September 1, 2023 will separately receive a final quarterly cash dividend of $0.75 per share on the Preferred Stock, payable on the conversion date.

About KKR
KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.

Contacts

Investor Relations:
Craig Larson
1-877-610-4910 (U.S.) / 212-230-9410
investor-relations@kkr.com

Media:
Kristi Huller, Miles Radcliffe-Trenner or Julia Kosygina
1-212-750-8300
media@kkr.com

KKR & Co. Inc.

NYSE:KKR

Release Versions

Contacts

Investor Relations:
Craig Larson
1-877-610-4910 (U.S.) / 212-230-9410
investor-relations@kkr.com

Media:
Kristi Huller, Miles Radcliffe-Trenner or Julia Kosygina
1-212-750-8300
media@kkr.com

More News From KKR & Co. Inc.

KKR & Co. Inc. Reports Second Quarter 2026 Results

NEW YORK--(BUSINESS WIRE)--KKR & Co. Inc. (NYSE: KKR) today reported its second quarter 2026 results, which have been posted to the Investor Center section of KKR’s website at https://ir.kkr.com/events-presentations/. A conference call to discuss KKR’s financial results will be held today, Thursday, July 30, 2026 at 9:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, th...

KKR Appoints Former Manulife CEO Roy Gori as Senior Advisor

NEW YORK--(BUSINESS WIRE)--KKR, a leading global investment firm, today announced the appointment of Roy Gori, former President and Chief Executive Officer of Manulife, as a Senior Advisor to the firm. Mr. Gori, an accomplished leader in the global insurance and financial services industry, will advise KKR on strategic opportunities across global financial services and insurance with a focus on Asia Pacific and international markets. He will provide strategic counsel across insurance, wealth ma...

KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries

NEW YORK--(BUSINESS WIRE)--KKR today announced the launch of Allyntra (“Allyntra” or the “Company”), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and...
Back to Newsroom